MiRNA-218 inhibits cell proliferation, migration and invasion by targeting Runt-related transcription factor 2

Qiang Guo1, Junan Ma2, Jing Wu3

  • 1Department of Thoracic Surgery, Jinan Fifth People's Hospital, No. 24297, Jingshi Road, Huaiyin District, Jinan City, Shandong, 250022, China.

Regenerative Therapy
|January 3, 2022
PubMed
Abstract

Insights

MicroRNA-218 (miRNA-218) suppresses osteosarcoma (OS) development and metastasis by targeting Runt-related transcription factor 2 (Runx2). This study reveals miRNA-218 as a potential therapeutic target for OS treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNA-218 (miRNA-218) deregulation is implicated in various cancers.
  • Runt-related transcription factor 2 (Runx2) is a key regulator in bone development and cancer progression.

Purpose of the Study:

  • To investigate the role of miRNA-218 in osteosarcoma (OS).
  • To determine if miRNA-218 targets Runx2 in OS cells.

Main Methods:

  • Quantified miRNA-218 and Runx2 expression in OS tissues and cell lines.
  • Overexpressed miRNA-218 in U2OS cells and assessed its impact on proliferation and metastasis using CCK8, colony formation, wound scratch, and Transwell assays.
  • Validated the interaction between miRNA-218 and Runx2 using TargetScan and dual-luciferase reporter assays.

Main Results:

  • MiRNA-218 was significantly downregulated in OS tissues and cell lines.
  • Overexpression of miRNA-218 inhibited OS cell proliferation and metastasis.
  • A negative correlation between miRNA-218 and Runx2 expression was observed.
  • Runx2 overexpression reversed the inhibitory effects of miRNA-218.

Conclusions:

  • MiRNA-218 acts as a tumor suppressor in OS by targeting Runx2.
  • This finding offers potential therapeutic strategies for osteosarcoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K